Erling Falk mainly investigates Internal medicine, Cardiology, Pathology, Thrombosis and Fibrous cap. Erling Falk works mostly in the field of Internal medicine, limiting it down to topics relating to Endocrinology and, in certain cases, Apolipoprotein E and Cancer research. Myocardial infarction is the focus of his Cardiology research.
He has researched Pathology in several fields, including Haematopoiesis, Stem cell and Coronary atherosclerosis. The various areas that Erling Falk examines in his Thrombosis study include Fibrosis and Unstable angina. His Fibrous cap research incorporates themes from Vulnerable plaque, Stenosis, Acute coronary syndrome and Biomedical engineering.
His scientific interests lie mostly in Internal medicine, Cardiology, Pathology, Radiology and Myocardial infarction. His research in Internal medicine focuses on subjects like Endocrinology, which are connected to Apolipoprotein E. Erling Falk regularly ties together related areas like Surgery in his Cardiology studies.
In his study, Edema is strongly linked to Inflammation, which falls under the umbrella field of Pathology. Erling Falk combines subjects such as Diabetes mellitus, Coronary atherosclerosis and Population study with his study of Myocardial infarction. He focuses mostly in the field of Thrombosis, narrowing it down to matters related to Unstable angina and, in some cases, Sudden death.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Statin, Primary prevention and Intensive care medicine. His work in Internal medicine is not limited to one particular discipline; it also encompasses Physical therapy. His Cardiology research includes themes of Abdominal aortic aneurysm, Prospective cohort study and PCSK9.
His Primary prevention study incorporates themes from Guideline and Statin treatment. In his research on the topic of Myocardial infarction, Stroke is strongly related with Population study. Disease is a subfield of Pathology that Erling Falk explores.
His primary areas of investigation include Internal medicine, Cardiology, Disease, Primary prevention and Intensive care medicine. Erling Falk performs multidisciplinary study in Internal medicine and Risk assessment in his work. In general Cardiology, his work in Blood flow is often linked to Shear stress linking many areas of study.
His Disease study combines topics from a wide range of disciplines, such as Animal model and Animal studies. The Primary prevention study combines topics in areas such as Statin therapy and Guideline. Intensive care medicine connects with themes related to Pathology in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Coronary Plaque Disruption
Erling Falk;Prediman K. Shah;Valentin Fuster.
Circulation (1995)
From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I
Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)
Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
J. S. Alpert;E. Antman;F. Apple;P. W. Armstrong.
European Heart Journal (2000)
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos.
European Heart Journal (2003)
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
P R Moreno;E Falk;I F Palacios;J B Newell.
Circulation (1994)
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi.
E Falk.
Heart (1983)
Pathogenesis of Atherosclerosis
Erling Falk.
Journal of the American College of Cardiology (2006)
Mechanisms of Plaque Formation and Rupture
Jacob Fog Bentzon;Fumiyuki Otsuka;Renu Virmani;Erling Falk.
Circulation Research (2014)
Update on acute coronary syndromes: the pathologists' view
Erling Falk;Masataka Nakano;Jacob Fog Bentzon;Aloke V. Finn.
European Heart Journal (2013)
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
Morteza Naghavi;Erling Falk;Harvey S. Hecht;Michael J. Jamieson.
American Journal of Cardiology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Icahn School of Medicine at Mount Sinai
Erasmus University Rotterdam
Copenhagen University Hospital
Cedars-Sinai Medical Center
Aarhus University Hospital
Utrecht University
Icahn School of Medicine at Mount Sinai
UCLA Medical Center
Icahn School of Medicine at Mount Sinai
National University of Ireland, Galway
University of California, Berkeley
Bielefeld University
Los Alamos National Laboratory
Ambys Medicines
Dartmouth College
University of Utah
University of Fribourg
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
University of Washington
University of Vienna
University of Copenhagen
University of California, San Diego
Jichi Medical University
University of North Carolina at Chapel Hill
Stanford University
Stanford University